Prognostic Biomarkers in Early-Stage B-CLL Patients
Chronic lymphocytic leukemia is one of the most common types of leukemia in adults. It belongs to the group of indolent lymphoproliferative disorders and has a slow clinical course. Approximately 50% of newly diagnosed patients do not require treatment for years. A better understanding of the pathop...
Saved in:
| Main Authors: | Vanya Popova, Vanya Slavcheva, Margarita Alexandrova, Tsvetan Lukanov, Silvia Naneva, Nikolay Tzvetkov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical University - Pleven
2018-03-01
|
| Series: | Journal of Biomedical & Clinical Research |
| Subjects: | |
| Online Access: | https://jbcr.arphahub.com/article/34480/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Beta-2 Microglobulin as Biomarker in Chronic Lymphocytic Leukemia
by: Nora M. Mahgoub, et al.
Published: (2024-12-01) -
Chronic Lymphocytic Leukemia: Investigation of Survival and Prognostic Factors with Drug-Related Remission
by: Gökhan Pektaş, et al.
Published: (2025-03-01) -
Expression of ZAP 70 in Chronic Lymphocytic Leukemia (CLL) and its Correlation with Clinical Stages
by: Zahra Tasleem, et al.
Published: (2024-01-01) -
Še dobro / Rai
by: Andrej Blatnik
Published: (2002-12-01) -
Changes of b2-microglobulin and electrolytes in different stages of COPD and their value in evaluating prognosis
by: Wang Lin, et al.
Published: (2024-01-01)